NCT04188808 Prospective Case-control Study in Patients With PAA
| NCT ID | NCT04188808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rebecka Hultgren |
| Condition | Popliteal Artery Aneurysm |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2018-09-01 |
| Primary Completion | 2024-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2018-09-01 with a primary completion date of 2024-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective is to highlight different aspects of care in patients with PAA before and after treatment, and identifying factors that influence the outcome of PAA patients.
Eligibility Criteria
Inclusion Criteria: * All patients scheduled for elective surgery of PAA (asymptomatic) * All patients scheduled for elective surgery of PAD * Elective open surgery * Intermittent claudication * Resting pain or very limited minor tissue loss Exclusion Criteria: * Cognitive failure * Major tissue loss * severe pain * if one cannot assimilate information in Swedish and understand the questionnaires
Contact & Investigator
Rebecka Hultgren, Prof
PRINCIPAL INVESTIGATOR
Karolinska Instutet
Frequently Asked Questions
Who can join the NCT04188808 clinical trial?
This trial is open to participants of all sexes, studying Popliteal Artery Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04188808 currently recruiting?
Yes, NCT04188808 is actively recruiting participants. Contact the research team at rebecka.hultgren@ki.se for enrollment information.
Where is the NCT04188808 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Stockholm, Sweden.
Who is sponsoring the NCT04188808 clinical trial?
NCT04188808 is sponsored by Rebecka Hultgren. The principal investigator is Rebecka Hultgren, Prof at Karolinska Instutet. The trial plans to enroll 130 participants.